< Back to the team

L.Perles

Lead Strategic Marketing & External Opportunities

Business development, Licensing & Marketing skills in EU with Non-dilutive funding experiences.

Léa Perles (PharmD, MSc) is specialized in external innovation & collaboration strategy, and benefits from various experiences in academic institutions and private companies in Europe, such as Sanofi Partnering.

Léa has successfully negotiated and managed pharmaceutical partnership alliances across EU and led communication and management strategies.

Linkedin-in

INCREASE IMMUNOGENICITY

Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system  with visible and multi-specific targets

More about Haptenization & STC immunogenicity
Back to the page

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

  • Representative oncogenic drivers (TP53,BRAF,KRAS,…)
  • Cold & hot tumor cell lines
  • Resistances capacities (metabolic ; chemical & physical)
Back to the page

Increase antigenicity

Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system  with a broad & higher quality range of tumor antigens

More about STC Antigenicity
Back to the page